Deepa Prasad - 15 Jun 2021 Form 3 Insider Report for Design Therapeutics, Inc. (DSGN)

Role
Director
Signature
/s/ Mustapha Parekh, Attorney-in-Fact
Issuer symbol
DSGN
Transactions as of
15 Jun 2021
Transactions value $
$0
Form type
3
Filing time
16 Jun 2021, 17:20:18 UTC
Next filing
21 Oct 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding DSGN Common Stock 1.48M 15 Jun 2021 By WRG Healthcare Fund I, LP F1
holding DSGN Common Stock 337K 15 Jun 2021 By WRG HCD1, LLC F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported securities are held directly by WRG Healthcare Fund I, LP. The reporting person is a member of the investment committee of WRG Healthcare Fund I, LP and may be deemed to have power to vote or dispose of these shares. The reporting person disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein.
F2 The reported securities are held directly by WRG HCD1, LLC. The reporting person is a member of WRG HCD1, LLC and may be deemed to have power to vote or dispose of these shares. The reporting person disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein.